Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection.

Steinbach JM, Weller CE, Booth CJ, Saltzman WM.

J Control Release. 2012 Aug 20;162(1):102-10. doi: 10.1016/j.jconrel.2012.06.008. Epub 2012 Jun 15.

PMID:
22705461
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.

Cun D, Foged C, Yang M, FrĂžkjaer S, Nielsen HM.

Int J Pharm. 2010 May 5;390(1):70-5. doi: 10.1016/j.ijpharm.2009.10.023. Epub 2009 Oct 15.

PMID:
19836438
[PubMed - indexed for MEDLINE]
3.

Polymeric nanoparticles for siRNA delivery and gene silencing.

Patil Y, Panyam J.

Int J Pharm. 2009 Feb 9;367(1-2):195-203. doi: 10.1016/j.ijpharm.2008.09.039. Epub 2008 Oct 1.

PMID:
18940242
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.

Jeon SY, Park JS, Yang HN, Woo DG, Park KH.

Biomaterials. 2012 Jun;33(17):4413-23. doi: 10.1016/j.biomaterials.2012.02.051. Epub 2012 Mar 15.

PMID:
22425025
[PubMed - indexed for MEDLINE]
5.

High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.

Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D, Foged C, Nielsen HM.

Eur J Pharm Biopharm. 2011 Jan;77(1):26-35. doi: 10.1016/j.ejpb.2010.11.008. Epub 2010 Nov 18.

PMID:
21093589
[PubMed - indexed for MEDLINE]
6.

Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model.

Scheinman RI, Trivedi R, Vermillion S, Kompella UB.

Nanomedicine (Lond). 2011 Dec;6(10):1669-82. doi: 10.2217/nnm.11.90. Epub 2011 Nov 17.

PMID:
22087799
[PubMed - indexed for MEDLINE]
7.

siRNA-chitosan complexes in poly(lactic-co-glycolic acid) nanoparticles for the silencing of aquaporin-1 in cancer cells.

Stigliano C, Aryal S, de Tullio MD, Nicchia GP, Pascazio G, Svelto M, Decuzzi P.

Mol Pharm. 2013 Aug 5;10(8):3186-94. doi: 10.1021/mp400224u. Epub 2013 Jun 21.

PMID:
23789777
[PubMed - indexed for MEDLINE]
8.

Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.

Pantazis P, Dimas K, Wyche JH, Anant S, Houchen CW, Panyam J, Ramanujam RP.

Methods Mol Biol. 2012;906:311-9. doi: 10.1007/978-1-61779-953-2_25.

PMID:
22791444
[PubMed - indexed for MEDLINE]
9.

PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.

Su WP, Cheng FY, Shieh DB, Yeh CS, Su WC.

Int J Nanomedicine. 2012;7:4269-83. doi: 10.2147/IJN.S33666. Epub 2012 Aug 3.

PMID:
22904633
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.

Feng SS, Mei L, Anitha P, Gan CW, Zhou W.

Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19.

PMID:
19299012
[PubMed - indexed for MEDLINE]
11.
12.

Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery.

Chen M, Gao S, Dong M, Song J, Yang C, Howard KA, Kjems J, Besenbacher F.

ACS Nano. 2012 Jun 26;6(6):4835-44. doi: 10.1021/nn300106t. Epub 2012 May 31.

PMID:
22621383
[PubMed - indexed for MEDLINE]
13.

Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy.

Nguyen J, Steele TW, Merkel O, Reul R, Kissel T.

J Control Release. 2008 Dec 18;132(3):243-51. doi: 10.1016/j.jconrel.2008.06.010. Epub 2008 Jun 19.

PMID:
18619502
[PubMed - indexed for MEDLINE]
14.

An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection.

Palliser D, Chowdhury D, Wang QY, Lee SJ, Bronson RT, Knipe DM, Lieberman J.

Nature. 2006 Jan 5;439(7072):89-94. Epub 2005 Nov 23.

PMID:
16306938
[PubMed - indexed for MEDLINE]
15.

The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis.

Park JS, Yang HN, Jeon SY, Woo DG, Kim MS, Park KH.

Biomaterials. 2012 Nov;33(33):8600-12. doi: 10.1016/j.biomaterials.2012.08.008. Epub 2012 Aug 18.

PMID:
22910222
[PubMed - indexed for MEDLINE]
16.

Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.

Jensen DK, Jensen LB, Koocheki S, Bengtson L, Cun D, Nielsen HM, Foged C.

J Control Release. 2012 Jan 10;157(1):141-8. doi: 10.1016/j.jconrel.2011.08.011. Epub 2011 Aug 12.

PMID:
21864597
[PubMed - indexed for MEDLINE]
17.

The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.

Yuan X, Shah BA, Kotadia NK, Li J, Gu H, Wu Z.

Pharm Res. 2010 Jul;27(7):1285-95. doi: 10.1007/s11095-010-0103-0. Epub 2010 Mar 23.

PMID:
20309616
[PubMed - indexed for MEDLINE]
18.

Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy.

Molavi O, Mahmud A, Hamdy S, Hung RW, Lai R, Samuel J, Lavasanifar A.

Mol Pharm. 2010 Apr 5;7(2):364-74. doi: 10.1021/mp900145g.

PMID:
20030320
[PubMed - indexed for MEDLINE]
19.

[Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].

Miao LF, Yang J, Huang CL, Song CX, Zeng YJ, Chen LF, Zhu WL.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):491-7. Chinese.

PMID:
18795627
[PubMed - indexed for MEDLINE]
Free Article
20.

Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.

Joung YK, Son S, Jang JY, Kwon MH, Park KD.

Pharm Res. 2012 Apr;29(4):932-42. doi: 10.1007/s11095-011-0633-0. Epub 2011 Dec 3.

PMID:
22139535
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk